drugset
drugset / Trial / NCT03058783

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects

NCT03058783 ↗

Phase 3 Completed 328 enrolled Bausch Health Americas, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects

Timeline

Start
2018-08-14
Primary completion
2020-05-12
Completion
2020-05-12

Drugs

EvaluationDrugModalityDoseRoute
Subject IDP-124 Unknown — Topical

Indications

atopic eczema